A detailed history of Fayez Sarofim & CO transactions in Agilent Technologies, Inc. stock. As of the latest transaction made, Fayez Sarofim & CO holds 3,101 shares of A stock, worth $417,115. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,101
Previous 3,101 -0.0%
Holding current value
$417,115
Previous $401,000 14.71%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$129.63 - $154.64 $27,870 - $33,247
215 Added 7.45%
3,101 $401,000
Q1 2023

May 11, 2023

SELL
$131.13 - $159.06 $11,277 - $13,679
-86 Reduced 2.89%
2,886 $399,000
Q4 2022

Feb 13, 2023

BUY
$125.64 - $157.68 $19,097 - $23,967
152 Added 5.39%
2,972 $444,000
Q2 2022

Aug 12, 2022

BUY
$112.71 - $135.93 $9,693 - $11,689
86 Added 3.15%
2,820 $335,000
Q2 2020

Aug 11, 2020

BUY
$68.92 - $91.14 $188,427 - $249,176
2,734 New
2,734 $242,000
Q1 2020

May 12, 2020

SELL
$63.37 - $90.13 $173,253 - $246,415
-2,734 Closed
0 $0
Q2 2019

Aug 09, 2019

BUY
$66.89 - $81.94 $182,877 - $224,023
2,734 New
2,734 $204,000

Others Institutions Holding A

About AGILENT TECHNOLOGIES, INC.


  • Ticker A
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 296,040,992
  • Market Cap $39.8B
  • Description
  • Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatogra...
More about A
Track This Portfolio

Track Fayez Sarofim & CO Portfolio

Follow Fayez Sarofim & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fayez Sarofim & CO, based on Form 13F filings with the SEC.

News

Stay updated on Fayez Sarofim & CO with notifications on news.